Startup Showcase: Jinfiniti: What do you think?

Comprehensive biomarker tech: Invest, buy, or both? It’s time to have your say on Jinfiniti.

We like what Jinfiniti are doing; but that’s just our opinion – you’re the ones with the buying power and the investment potential: What do you think?

  • Watch the video pitch and investor questions;
  • Check-out the slide deck;
  • Take the 30 secs survey and see what others think!

The video pitch and investor questions:

The slide deck:

Jinfiniti Pich Deck Longevity.Technology

The 30-second survey (with live results):

Would you like to know more?

We’re happy to pass along your comments and questions to the Jinfiniti team: you can email us via this link. Thanks.


Thanks for engaging – we have regular Startup Showcases coming-up: stay tuned!

Phil Newman
Editor-in-Chief Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity, a media and finance business focused on bringing together innovators and investors to commercialise the companies that will form the Longevity economy.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.
ChromaDex TruNiagen
ChromaDex TruNiagen

Latest articles